Skip to main content
. 2020 Nov 24;17(23):8740. doi: 10.3390/ijerph17238740

Figure 2.

Figure 2

Figure 2

(a) Distribution of musculoskeletal disorder (MSD) among all participants (n = 450), female participants (n = 287) and male participants over lifetime. (b) Distribution of MSD among all participants (n = 450), female participants (n = 287) and male participants for 12-month prevalence. (c) Distribution of MSD among all participants (n = 450), female participants (n = 287) and male participants for 7-day prevalence. * means p < 0.05.